Literature DB >> 9616236

In vivo assessment of neovascularization of liver metastases using perfusion CT.

K A Miles1, D A Leggett, B B Kelley, M P Hayball, R Sinnatamby, I Bunce.   

Abstract

Neovascularization of tumours produces a high microvessel density. Although diagnostic imaging is unable to visualize microvessels directly, it is possible to demonstrate associated changes in tissue perfusion. The aim of this study was to use the quantitative functional information and high spatial resolution of perfusion computed tomography to study neovascularization of hepatic metastases. Perfusion CT was performed in 13 patients with hepatic metastases from various primary tumours. Arterial perfusion was measured in the metastasis; both arterial and portal perfusion were measured in a small rim of liver tissue immediately adjacent to the metastasis. Perfusion measurements were correlated against survival of the patient in nine cases. Arterial perfusion was increased above normal values, both in the metastasis (median: 0.62 ml min-1 ml-1; range: 0.26-3.05 ml min-1 ml-1) and in the adjacent liver (median: 0.51 ml min-1 ml-1; range: 0.14-1.60 ml min-1 ml-1). Portal perfusion of adjacent liver was highly variable (median: 0.30 ml min-1 ml-1; range: 0.05-1.85 ml min-1 ml-1). Arterial perfusion was positively correlated with portal perfusion within liver tissue adjacent to metastases (p < 0.05, r = 0.58), a reversal of the normal situation. Survival of the patient correlated with arterial perfusion within the metastasis (p < 0.05, r = 0.69) but more closely with arterial perfusion in the adjacent liver (p < 0.02, r = 0.78). In conclusion, alterations in perfusion within metastases and adjacent liver are in accordance with the histological features of neovascularization. Perfusion CT offers a method for studying neovascularization in the living patient and offers prognostic information.

Entities:  

Mesh:

Year:  1998        PMID: 9616236     DOI: 10.1259/bjr.71.843.9616236

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  24 in total

1.  Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.

Authors:  Davide Ippolito; Cristina Capraro; Alessandra Casiraghi; Cristina Cestari; Sandro Sironi
Journal:  Eur Radiol       Date:  2011-11-16       Impact factor: 5.315

2.  Perfusion computed tomography evaluation of angiogenesis in liver cancer.

Authors:  Han Feng Yang; Yong Du; Jia Xiang Ni; Xiang Ping Zhou; Jin Dong Li; Qing Zhang; Xiao Xue Xu; Yang Li
Journal:  Eur Radiol       Date:  2010-02-24       Impact factor: 5.315

Review 3.  Imaging tumour angiogenesis.

Authors:  Tony Jeswani; Anwar R Padhani
Journal:  Cancer Imaging       Date:  2005-12-01       Impact factor: 3.909

4.  Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate.

Authors:  Elie Oussoultzoglou; Philippe Bachellier; Edoardo Rosso; Radu Scurtu; Ioan Lucescu; Michel Greget; Daniel Jaeck
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

5.  Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling.

Authors:  Tong San Koh; Choon Hua Thng; Septian Hartono; Puor Sherng Lee; Su Pin Choo; Donald Y H Poon; Han Chong Toh; Sotirios Bisdas
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

Review 6.  SIRT of liver metastases: physiological and pathophysiological considerations.

Authors:  Christophe Van de Wiele; Alex Maes; Eddy Brugman; Yves D'Asseler; Bart De Spiegeleer; Gilles Mees; Karin Stellamans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

7.  Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver?

Authors:  Y Tsushima; M J Blomley; H Yokoyama; S Kusano; K Endo
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

8.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.

Authors:  Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
Journal:  Eur Radiol       Date:  2006-10-27       Impact factor: 5.315

Review 9.  Hijacking the vasculature in ccRCC--co-option, remodelling and angiogenesis.

Authors:  Chao-Nan Qian
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

10.  Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Authors:  Yun Shin Chun; Jean-Nicolas Vauthey; Piyaporn Boonsirikamchai; Dipen M Maru; Scott Kopetz; Martin Palavecino; Steven A Curley; Eddie K Abdalla; Harmeet Kaur; Chusilp Charnsangavej; Evelyne M Loyer
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.